Why the PolyNovo (ASX:PNV) share price is zooming 7% higher today

The PolyNovo Ltd (ASX:PNV) share price is zooming higher on Wednesday following the release of two positive announcements…

| More on:
A young man pointing up looking amazed, indicating a surging share price movement for an ASX company

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The PolyNovo Ltd (ASX: PNV) share price is pushing higher this morning following the release of a couple of positive announcements.

At the time of writing, the medical device company's shares are up 7% to $2.66.

What did PolyNovo announce?

This morning PolyNovo announced that it has expanded its presence in Europe by entering into both the Poland and Turkey markets.

In respect to Poland, the company has appointed Hortho Medical Innovations as its exclusive distributor in the country.

According to the release, Hortho distributes modern and innovative devices for medical reconstruction. This includes a number of complementary bio-absorbable implant technologies.

It also works closely with key opinion leaders in plastic/reconstructive surgery and has a direct team servicing all of Poland. Hortho plans to add dedicated personnel to support NovoSorb BTM sales and marketing activities.

The company notes that Poland is the sixth largest country in the European Union with a population of more than 38 million, and a medical device market valued at over $2.2 billion.

PolyNovo's Managing Director, Paul Brennan, said: "Poland is an exciting growth market in Europe and we see this partnership as an important step in expanding our sales in Europe."

What about Turkey?

Over in Turkey, PolyNovo has appointed Incomed Saglik Hiz and its medical sales channel LotuS as its distributor.

It notes that this expansion into the Europe-Middle East-Africa (EMEA) region is a big step in bringing NovoSorb BTM to a significant number of surgeons and patients in the region.

LotuS has an established product portfolio and sales relationships within wound and burn treatment. It also has over 10 years' experience launching innovative devices through its extensive customer base.

Management advised that LotuS is the distributor of Suprathel (an artificial wound and burn dressing) and is familiar with the benefits of synthetic products in the treatment of complex surgical wounds. NovoSorb BTM will complete its plastic and reconstructive surgery offering.

Mr Brennan commented: "We are excited by our partnership with LotuS mcd and our entry into Turkey. The country is an important geographical and commercial link in our European, Mediterranean and Middle East strategy. We will now be able to service surgeons who work across EMEA and expand the inter-surgeon referral of the benefits of NovoSorb BTM."

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »